Chromogranin A regulates gut permeability via the antagonistic actions of its proteolytic peptides

作者: Elke M. Muntjewerff , Kechun Tang , Lisanne Lutter , Gustaf Christoffersson , Mara J.T. Nicolasen

DOI: 10.1101/2020.09.19.304303

关键词:

摘要: Background and AimsA leaky gut barrier has been implicated in the initiation progression of a multitude diseases, e.g., inflammatory bowel disease, irritable syndrome, celiac colorectal cancers. Here we asked how Chromogranin A (CgA), major hormone produced by enteroendocrine cells, Catestatin (CST), most abundant CgA-derived proteolytic peptide, affect barrier. Methods ResultsUltrastructural studies on colons from (CST: hCgA352-372) knockout (CST-KO) mice revealed (i) altered morphology tight (TJ) adherens (AJ) junctions desmosomes, indicative junctional stress (ii) an increased infiltration immune cells compared to controls. Flow cytometry confirmed these be macrophages CD4+ T cells. Gene expression that multiple TJ-markers were reduced, with concomitant compensatory elevation AJ desmosome markers. Consistently, levels plasma FITC-dextran elevated CST-KO mice, confirming leakiness gut. Leaky correlated inflammation higher ratio Firmicutes Bacteroidetes, dysbiotic pattern commonly encountered diseases. Supplementation recombinant CST reversed this key phenotypes. CgA-KO either alone, or pro-inflammatory CgA fragment pancreastatin (PST: CgA250-301) showed permeability is regulated antagonistic roles two peptide hormones: reduces PST increases leakiness. ConclusionWe conclude cell-derived hormone, regulates permeability. both necessary sufficient reduce acts primarily via antagonizing effects PST. What you need knowO_ST_ABSBackground ContextC_ST_ABSThe intestinal disrupted many diseases such as Crohns disease. (CgA) proteolytically cleaved into bioactive peptides including catestatin (CST) (PST). The role unknown. New findingsCgA efficiently processed processing might decreased during active promotes epithelial function counteracting LimitationsThe complete mechanism regulation likely involves complex interplay between system, metabolism, epithelium, system microbiota. ImpactOur findings indicate modulator functions correlates disease severity could target for therapeutic interventions

参考文章(105)
J.S. Videen, M.S. Mezger, Y.M. Chang, D.T. O'Connor, Calcium and catecholamine interactions with adrenal chromogranins. Comparison of driving forces in binding and aggregation. Journal of Biological Chemistry. ,vol. 267, pp. 3066- 3073 ,(1992) , 10.1016/S0021-9258(19)50695-0
Ricardo Borges, Jésica Díaz‐Vera, Natalia Domínguez, María Rosa Arnau, José D Machado, None, Chromogranins as regulators of exocytosis. Journal of Neurochemistry. ,vol. 114, pp. 335- 343 ,(2010) , 10.1111/J.1471-4159.2010.06786.X
Rana Al-Sadi, Dongmei Ye, Karol Dokladny, Thomas Y. Ma, Mechanism of IL-1β-Induced Increase in Intestinal Epithelial Tight Junction Permeability Journal of Immunology. ,vol. 180, pp. 5653- 5661 ,(2008) , 10.4049/JIMMUNOL.180.8.5653
Takuya Suzuki, Naho Yoshinaga, Soichi Tanabe, Interleukin-6 (IL-6) Regulates Claudin-2 Expression and Tight Junction Permeability in Intestinal Epithelium Journal of Biological Chemistry. ,vol. 286, pp. 31263- 31271 ,(2011) , 10.1074/JBC.M111.238147
Qijiao Jiang, Laurent Taupenot, Sushil K. Mahata, Manjula Mahata, Daniel T. O'Connor, Lindsey A. Miles, Robert J. Parmer, Proteolytic cleavage of chromogranin A (CgA) by plasmin. Selective liberation of a specific bioactive CgA fragment that regulates catecholamine release. Journal of Biological Chemistry. ,vol. 276, pp. 25022- 25029 ,(2001) , 10.1074/JBC.M101545200
B Johne, M K Fagerhol, T Lyberg, H Prydz, P Brandtzaeg, C F Naess-Andresen, I Dale, Functional and clinical aspects of the myelomonocyte protein calprotectin. Molecular pathology : MP. ,vol. 50, pp. 113- 123 ,(1997) , 10.1136/MP.50.3.113
Christopher D Packey, R Balfour Sartor, Commensal bacteria, traditional and opportunistic pathogens, dysbiosis and bacterial killing in inflammatory bowel diseases. Current Opinion in Infectious Diseases. ,vol. 22, pp. 292- 301 ,(2009) , 10.1097/QCO.0B013E32832A8A5D
Michael Wagner, Mats Stridsberg, Christer G. B. Peterson, Per Sangfelt, Maria Lampinen, Marie Carlson, Increased Fecal Levels of Chromogranin A, Chromogranin B, and Secretoneurin in Collagenous Colitis Inflammation. ,vol. 36, pp. 855- 861 ,(2013) , 10.1007/S10753-013-9612-4
Hans Strid, Magnus Simrén, Anders Lasson, Stefan Isaksson, Mats Stridsberg, Lena Öhman, Fecal chromogranins and secretogranins are increased in patients with ulcerative colitis but are not associated with disease activity. Journal of Crohn's and Colitis. ,vol. 7, ,(2013) , 10.1016/J.CROHNS.2013.04.019
Jean C. Lee, Carolyn V. Taylor, Sara P. Gaucher, Thomas Toneff, Laurent Taupenot, Sukkid Yasothornsrikul, Sushil K. Mahata, Catherine Sei, Robert J. Parmer, John M. Neveu, William S. Lane, Bradford W. Gibson, Daniel T. O'Connor, Vivian Y. H. Hook, Primary sequence characterization of catestatin intermediates and peptides defines proteolytic cleavage sites utilized for converting chromogranin a into active catestatin secreted from neuroendocrine chromaffin cells. Biochemistry. ,vol. 42, pp. 6938- 6946 ,(2003) , 10.1021/BI0300433